TARGETWATCH
IMImmunovia
Immunovia
Siste kurs
0,18 SEK
22.7.2026
IMMNOV
3 mnd 
6 mnd 
1 år 
Maks+131047,54%1 kursmål
Danske Bank
HelsevesenDiagnostics & Research

Om selskapet

Immunovia AB is a Swedish listed medical technology company. The company develops tools for diagnosing diseases. Blood samples provide biomarker signatures specific to each disease. The first test concerns pancreatic cancer and is now undergoing final validation studies.
Wikipedia

Innsidehandel for Immunovia

Ingen innsidehandler for valgt periode.

Flere kursmål for Immunovia

Analytiker
Dato
Sep -21
Kursmål
240,00 SEK